Results 261 to 270 of about 270,592 (355)
The Role of Narcotics (Morphine) in Postoperative Morbidity.
John H. Strickler, Carl O. Rice
openalex +1 more source
Serious Adverse Drug Reactions to Long-Term Oral Liquid Morphine in Patients with Chronic Pain: A Cross-Sectional Survey in Palliative Care. [PDF]
Duncan B+5 more
europepmc +1 more source
Abstract Background and Purpose Opioid use disorder (OUD) is a pressing public health concern marked by frequent relapse during periods of abstinence, perpetuated by negative affective states. Classical antidepressants or the currently prescribed opioid pharmacotherapies have limited efficacy to reverse the negative affect or prevent relapse ...
Andria Michael+7 more
wiley +1 more source
Faecal Microbiota Transplantation Modulates Morphine Addictive-Like Behaviours Through Hippocampal Metaplasticity. [PDF]
Saeedi N+6 more
europepmc +1 more source
Background and Purpose Heroin and cocaine users tailor their dosage, frequency and administration route to maximise the drugs' effects or prevent withdrawal symptoms. Counterintuitively, preclinical self‐administration and choice experiments employ, almost invariably and regardless of the pharmacokinetic properties of the drug under examination, fixed ...
Ginevra D'Ottavio+18 more
wiley +1 more source
Effects of intravenous morphine and lidocaine on bacterial growth. [PDF]
Osoian CI+5 more
europepmc +1 more source
Abstract Background and Purpose Morphine is among the most powerful analgesic, but its long‐term use can cause tolerance. Synaptic ATP supply is critical for maintaining synaptic transmission. Microtubule‐based mitochondrial transport ensures synaptic energy supply.
Zheng Li+9 more
wiley +1 more source
A small molecule PKCε inhibitor reduces hyperalgesia induced by paclitaxel or opioid withdrawal. [PDF]
Gregory-Flores A+11 more
europepmc +1 more source
Abstract Background and Purpose Binge drinking is a risky pattern of alcohol intake and a major predictor of alcohol use disorder (AUD). Current AUD medications have limited efficacy and poor patient compliance, calling for more effective therapeutics.
Connie J. Badolato+4 more
wiley +1 more source